Sandra I. Aguiar

1.5k total citations
36 papers, 1.1k citations indexed

About

Sandra I. Aguiar is a scholar working on Epidemiology, Molecular Biology and Microbiology. According to data from OpenAlex, Sandra I. Aguiar has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Molecular Biology and 11 papers in Microbiology. Recurrent topics in Sandra I. Aguiar's work include Pneumonia and Respiratory Infections (13 papers), Bacterial Infections and Vaccines (9 papers) and Respiratory viral infections research (8 papers). Sandra I. Aguiar is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Bacterial Infections and Vaccines (9 papers) and Respiratory viral infections research (8 papers). Sandra I. Aguiar collaborates with scholars based in Portugal, United States and United Kingdom. Sandra I. Aguiar's co-authors include Mário Ramirez, José Melo‐Cristino, Frederico Aires‐da‐Silva, Joana Dias, Francisco Pinto, Pedro Bule, Isa Serrano, Maria Manuela Gaspar, Luís Tavares and Solange Gil and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Scientific Reports.

In The Last Decade

Sandra I. Aguiar

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sandra I. Aguiar

Since Specialization

Citations

This map shows the geographic impact of Sandra I. Aguiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra I. Aguiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra I. Aguiar more than expected).

Fields of papers citing papers by Sandra I. Aguiar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra I. Aguiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra I. Aguiar. The network helps show where Sandra I. Aguiar may publish in the future.

Co-authorship network of co-authors of Sandra I. Aguiar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra I. Aguiar. A scholar is included among the top collaborators of Sandra I. Aguiar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra I. Aguiar. Sandra I. Aguiar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthetic Osmolytes for Enhanced RNA Thermotolerance and Extended Plasmid Storage at Room Temperature 2025 ·Biotechnology Journal ·Catarina Amaral, (unknown), (unknown), (unknown), Sandra I. Aguiar, (unknown), M. Rita Ventura, Catarina Pimentel	2
2	Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates 2024 ·Frontiers in Microbiology ·(unknown), Margarida Pinto, Frederico Aires‐da‐Silva, Ana Bettencourt, Maria Manuela Gaspar, Sandra I. Aguiar	2
3	Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma 2023 ·Frontiers in Veterinary Science ·(unknown), Joana Dias, Sandra I. Aguiar, (unknown), (unknown), Joana D. Amaral, Célia Fernandes, Lurdes Gano, João D. G. Correia, Marco Cavaco, Vera Neves, Jorge Correia, Miguel A. R. B. Castanho, Cecília M. P. Rodrigues, Maria Manuela Gaspar, Luís Tavares, Frederico Aires‐da‐Silva	1
4	Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy 2022 ·Scientific Reports ·Joana Dias, (unknown), (unknown), Sandra I. Aguiar, Pedro Bule, (unknown), (unknown), (unknown), Solange Gil, Luís Tavares, Frederico Aires‐da‐Silva	8
5	Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy 2021 ·International Journal of Molecular Sciences ·Pedro Bule, Sandra I. Aguiar, Frederico Aires‐da‐Silva, Joana Dias	131
6	Diazaborines Are a Versatile Platform to Develop ROS‐Responsive Antibody Drug Conjugates** 2021 ·Angewandte Chemie International Edition ·João P. M. António, (unknown), (unknown), Joana Dias, Sandra I. Aguiar, Hélio Faustino, (unknown), Luı́s F. Veiros, Gonçalo J. L. Bernardes, Frederico Aires‐da‐Silva, Pedro M. P. Góis	29
7	Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance 2021 ·Molecules ·(unknown), (unknown), Joana Dias, Marta Silva, Solange Gil, Luís Tavares, Frederico Aires‐da‐Silva, Maria Manuela Gaspar, Sandra I. Aguiar	148
8	Diazaborines Are a Versatile Platform to Develop ROS‐Responsive Antibody Drug Conjugates** 2021 ·Angewandte Chemie ·João P. M. António, (unknown), (unknown), Joana Dias, Sandra I. Aguiar, Hélio Faustino, (unknown), Luı́s F. Veiros, Gonçalo J. L. Bernardes, Frederico Aires‐da‐Silva, Pedro M. P. Góis	1
9	Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening 2021 ·Pharmaceutics ·Sandra I. Aguiar, Joana Dias, (unknown), Marta Silva, Diana Martins, (unknown), Miguel A. R. B. Castanho, João André Carriço, Marco Cavaco, Maria Manuela Gaspar, Rui Jorge Nobre, Luís Pereira de Almeida, (unknown), Lurdes Gano, João D. G. Correia, Carlos F. Barbas, João Gonçalves, Vera Neves, Frederico Aires‐da‐Silva	21
10	Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma 2021 ·Frontiers in Veterinary Science ·Joana Dias, (unknown), Sandra I. Aguiar, Solange Gil, Luís Tavares, Frederico Aires‐da‐Silva	13
11	Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis 2021 ·Cell Host & Microbe ·Sumnima Singh, Jessica A. Thompson, Bahtiyar Yılmaz, Hai Li, Sebastian Weis, Daniel Sobral, Mauro Truglio, Frederico Aires‐da‐Silva, Sandra I. Aguiar, Ana Rita Carlos, Sofia Rebelo, Sílvia Cardoso, Erida Gjini, Gabriel Núñez, Miguel P. Soares	14
12	Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors 2020 ·Drug Delivery and Translational Research ·(unknown), Sandra I. Aguiar, Ana Bettencourt, Maria Manuela Gaspar	20
13	Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies 2018 ·PLoS ONE ·Joana Dias, (unknown), Sandra I. Aguiar, (unknown), (unknown), Maria C. Peleteiro, Barbara C. Rütgen, Lurdes Gano, João D. G. Correia, (unknown), João Gonçalves, Solange Gil, Luís Tavares, Frederico Aires‐da‐Silva	4
14	Clonal and serotype dynamics of serogroup 6 isolates causing invasive pneumococcal disease in Portugal: 1999-2012 2017 ·PLoS ONE ·(unknown), Sandra I. Aguiar, João André Carriço, José Melo‐Cristino, Mário Ramirez	8
15	The Majority of Adult Pneumococcal Invasive Infections in Portugal Are Still Potentially Vaccine Preventable in Spite of Significant Declines of Serotypes 1 and 5 2013 ·PLoS ONE ·(unknown), (unknown), Sandra I. Aguiar, Mário Ramirez, José Melo‐Cristino, (unknown)	24
16	miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells 2013 ·Journal of Hematology & Oncology ·Ana Costa, Joana Afonso, Catarina Osório, Ana L. Gomes, Francisco Caiado, J.F.A. Valente, Sandra I. Aguiar, Francisco Pinto, Mário Ramirez, Sérgio Dias	26
17	Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections 2011 ·Vaccine ·(unknown), (unknown), Sandra I. Aguiar, Mário Ramirez, José Melo‐Cristino	26
18	Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use 2010 ·Vaccine ·Sandra I. Aguiar, Maria João Brito, José Gonçalo Marques, José Melo‐Cristino, Mário Ramirez	56
19	Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine 2008 ·Clinical Microbiology and Infection ·Sandra I. Aguiar, Isa Serrano, Francisco Pinto, José Melo‐Cristino, Mário Ramirez	67
20	The presence of the pilus locus is a clonal property among pneumococcal invasive isolates 2008 ·BMC Microbiology ·Sandra I. Aguiar, Isa Serrano, Francisco Pinto, José Melo‐Cristino, Mário Ramirez	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact